Le Lézard
Classified in: Health
Subject: MAT

Gastric Sleeve Surgery's Power Highlighted by TV's Kelly Osbourne's 85 Pound Weight Loss Success Story, says Beverly Hills Physicians


LOS ANGELES, Aug. 28, 2020 /PRNewswire-PRWeb/ -- An August 20 article on Extra TV reports on British television personality Kelly Osbourne's impressive 85-pound weight loss through gastric sleeve surgery. The former teen star of the 2000s reality sitcom, "The Osbournes," spoke about how she believes that the procedure was the best decision she had ever made and that she will always be proud to talk about a subject that might make many people uncomfortable. Ms. Osbourne stressed that the surgery was by no means a quick fix for her problems and encouraged others to think seriously about whether or not the procedure would be right for them. Southern California health and beauty medical group Beverly Hills Physicians agrees that, while the journey to effective, long-term weight loss cannot be achieved overnight, weight loss procedures such as sleeve gastrectomy can provide enormous benefits for individuals struggling to defeat obesity.

The Los Angeles-based medical group notes that weight loss surgeries like sleeve gastrectomy are popular due to the procedure's ability to set patients up for long-term weight loss success. The treatment removes most of the stomach and limits how much an individual can comfortably eat. In the article, Ms. Osbourne noted that the procedure reduces cravings. Beverly Hills Physicians confirms that, by minimizing hunger signals produced by the body, significant and permanent weight loss becomes much easier to achieve compared to trying to drastically change eating habits unaided. Incessant cravings to overeat may be among the main reasons that the large majority of weight loss attempts without surgery fail sooner or later, says the medical group.

Beverly Hills Physicians says that it's not news that individuals battling obesity are also at increased risk for several life-threatening illnesses such as diabetes, heart disease, cancer, and strokes. The clinic adds that losing excess weight not only reduces the chances of developing these often debilitating conditions, it also helps to improve the individual's overall quality of life, from reduced strain on joints to improved energy levels that enable patients to maintain an active and healthy lifestyle.

The medical group adds that there are a growing number of effective treatments for people struggling with obesity. By speaking with qualified medical professionals, the clinic says that reaching a stable and safe weight is more achievable than ever.

Readers interested in learning more about weight loss surgery with Southern California health and beauty medical group Beverly Hills Physicians can call 800-670-3602 or visit the clinic's website at https://www.beverlyhillsphysicians.com/.

 

SOURCE Beverly Hills Physicians


These press releases may also interest you

at 22:03
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

at 22:00
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

at 21:45
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

at 21:30
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare's novel SHP2 (Src Homology 2 domain containing...



News published on and distributed by: